CMS Takes Action to Modernize Medicare Home
Health
On October 31, CMS finalized significant
changes to the Home Health Prospective Payment System (PPS) to strengthen and
modernize Medicare. Specifically, CMS made changes to improve access to
solutions via remote patient monitoring technology, updated payments for home
health care with a new case-mix system, begin the new home infusion therapy
benefit, and reduce burden.
“This home health final rule focuses on
patient needs and not on the volume of care,” said CMS Administrator Seema
Verma. “This rule also innovates and modernizes home health care by
allowing remote patient monitoring. We are also proud to offer new home
infusion therapy services. Using new technology and reducing
unnecessary reporting measures for certifying physicians will result in an
annual cost savings and provide Home Health Agencies (HHAs) and doctors what
they need to give patients a personalized treatment plan that will result in
better health outcomes.”
Beginning with CY 2020, CMS is implementing
changes required by law, including a new case-mix system called the
Patient-Driven Groupings Model (PDGM) that puts the focus on patient needs
rather than volume of care. The PDGM relies more heavily on patient
characteristics to more accurately pay for home health services.
CMS is promoting innovation and modernization
of home health care by allowing the cost of remote patient monitoring to be
reported by home health agencies as allowable costs on the Medicare cost
report form. This is expected to help foster the adoption of emerging
technologies by home health agencies and result in more effective care
planning, as data are shared among patients, their caregivers and their
providers. The use of such technology can allow for greater patient
independence and empowerment. Supporting patients in sharing their data will
advance the MyHealthEData initiative.
This final rule implements the temporary
transitional payments for home infusion therapy services for CYs 2019 and
2020, as required by the Bipartisan Budget Act of 2018, until the new
permanent home infusion therapy services benefit begins on January 1, 2021.
In addition, the final rule establishes the health and safety standards for
qualified home infusion therapy suppliers of the new permanent home infusion
therapy service benefit. The final rule also establishes the approval and
oversight process for accrediting organizations of these suppliers as
required by the 21st Century Cures Act. We are finalizing our
proposal and also seeking further comments on our interpretation of “infusion
drug administration calendar day” and on its potential effects on access to
care.
CMS is eliminating the requirement that the
certifying physician estimate how much longer home health services are needed
when recertifying the need for continued home health care. This results
in an estimated reduction in burden for physicians of $14.2 million,
annually, and would allow physicians to spend more time with patients rather
than on unnecessary paperwork.
The final rule helps advance the
Comprehensive Meaningful Measures Initiative. CMS is removing seven Home
Health Quality Reporting Program measures. Changes in data collection under
the new case-mix system, coupled with the changes from these seven measure
removals will reduce burden for HHAs by approximately $60 million annually,
beginning in CY 2020.
For More Information:
Like our newsletter? Have suggestions? Please let us
know!
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Friday, November 2, 2018
CMS Takes Action to Modernize Medicare Home Health
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment